Atea Pharmaceuticals, Inc.AVIRNASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank57
3Y CAGR-17.1%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
-17.1%/yr
Annual compound
Percentile
P57
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
3 yr
Consecutive declineElevated
PeriodValueYoY Change
20250.00-24.3%
20240.00-12.5%
20230.00-13.8%
20220.00+1738.3%
20210.00-
20200.00-
20190.00-
20180.00-